目次

Executive Summary
Market Overview

Market Landscape
Market ecosystem
Value chain analysis

Market Sizing
Market definition
Market size 2021
Market segment analysis
Market outlook: Forecast for 2021 - 2026

Five Forces Analysis
Five Forces Summary
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

Market Segmentation by Route of administration
Market segments
Comparison by Route of administration
Oral - Market size and forecast 2021-2026
Injectable - Market size and forecast 2021-2026
Pulmonary - Market size and forecast 2021-2026
Others - Market size and forecast 2021-2026
Market opportunity by Route of administration

Customer landscape
Overview

Geographic Landscape
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2021-2026
Europe - Market size and forecast 2021-2026
Asia - Market size and forecast 2021-2026
ROW - Market size and forecast 2021-2026
Key leading countries
Market opportunity by geography

Drivers, Challenges, and Trends
Market drivers
Market challenges
Market trends

Vendor Landscape
Competitive Scenario
Overview
Landscape disruption

Vendor Analysis
Vendors covered
Market positioning of vendors
3M Co.
AbbVie Inc.
Antares Pharma Inc.
Becton Dickinson and Co.
BIOCORP Production
F. Hoffmann La Roche Ltd.
Johnson and Johnson Inc.
Novartis AG
Pfizer Inc.

Appendix
Scope of the report
Currency conversion rates for US$
Research Methodology
List of abbreviations

Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2021 - 2026 ()
13: Global market: Year-over-year growth 2021 - 2026 (%)
14: Five forces analysis 2021 & 2026
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2021
21: Route of administration - Market share 2021-2026 (%)
22: Comparison by Route of administration
23: Oral - Market size and forecast 2021-2026 ()
24: Oral - Year-over-year growth 2021-2026 (%)
25: Injectable - Market size and forecast 2021-2026 ()
26: Injectable - Year-over-year growth 2021-2026 (%)
27: Pulmonary - Market size and forecast 2021-2026 ()
28: Pulmonary - Year-over-year growth 2021-2026 (%)
29: Others - Market size and forecast 2021-2026 ()
30: Others - Year-over-year growth 2021-2026 (%)
31: Market opportunity by Route of administration
32: Customer landscape
33: Market share by geography 2021-2026 (%)
34: Geographic comparison
35: North America - Market size and forecast 2021-2026 ()
36: North America - Year-over-year growth 2021-2026 (%)
37: Europe - Market size and forecast 2021-2026 ()
38: Europe - Year-over-year growth 2021-2026 (%)
39: Asia - Market size and forecast 2021-2026 ()
40: Asia - Year-over-year growth 2021-2026 (%)
41: ROW - Market size and forecast 2021-2026 ()
42: ROW - Year-over-year growth 2021-2026 (%)
43: Key leading countries
44: Market opportunity by geography ()
45: Impact of drivers and challenges
46: Vendor landscape
47: Landscape disruption
48: Industry risks
49: Vendors covered
50: Market positioning of vendors
51: 3M Co. - Overview
52: 3M Co. - Business segments
53: 3M Co. - Key offerings
54: 3M Co. - Key customers
55: 3M Co. - Segment focus
56: AbbVie Inc. - Overview
57: AbbVie Inc. - Business segments
58: AbbVie Inc. - Key offerings
59: AbbVie Inc. - Key customers
60: AbbVie Inc. - Segment focus
61: Antares Pharma Inc. - Overview
62: Antares Pharma Inc. - Business segments
63: Antares Pharma Inc. - Key offerings
64: Antares Pharma Inc. - Key customers
65: Antares Pharma Inc. - Segment focus
66: Becton Dickinson and Co. - Overview
67: Becton Dickinson and Co. - Business segments
68: Becton Dickinson and Co. - Key offerings
69: Becton Dickinson and Co. - Key customers
70: Becton Dickinson and Co. - Segment focus
71: BIOCORP Production - Overview
72: BIOCORP Production - Business segments
73: BIOCORP Production - Key offerings
74: BIOCORP Production - Key customers
75: BIOCORP Production - Segment focus
76: F. Hoffmann La Roche Ltd. - Overview
77: F. Hoffmann La Roche Ltd. - Business segments
78: F. Hoffmann La Roche Ltd. - Key offerings
79: F. Hoffmann La Roche Ltd. - Key customers
80: F. Hoffmann La Roche Ltd. - Segment focus
81: Johnson and Johnson Inc. - Overview
82: Johnson and Johnson Inc. - Business segments
83: Johnson and Johnson Inc. - Key offerings
84: Johnson and Johnson Inc. - Key customers
85: Johnson and Johnson Inc. - Segment focus
86: Novartis AG - Overview
87: Novartis AG - Business segments
88: Novartis AG - Key offerings
89: Novartis AG - Key customers
90: Novartis AG - Segment focus
91: Pfizer Inc. - Overview
92: Pfizer Inc. - Business segments
93: Pfizer Inc. - Key offerings
94: Pfizer Inc. - Key customers
95: Pfizer Inc. - Segment focus
96: Teva Pharmaceutical Industries Ltd. - Overview
97: Teva Pharmaceutical Industries Ltd. - Business segments
98: Teva Pharmaceutical Industries Ltd. - Key offerings
99: Teva Pharmaceutical Industries Ltd. - Key customers
100: Teva Pharmaceutical Industries Ltd. - Segment focus
101: Currency conversion rates for US$
102: Research Methodology
103: Validation techniques employed for market sizing
104: Information sources
105: List of abbreviations